{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:40:12Z","timestamp":1733056812670,"version":"3.30.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4048,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1002\/hep.20344","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T16:10:54Z","timestamp":1092413454000},"page":"499-500","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Infliximab and alcoholic hepatitis"],"prefix":"10.1097","volume":"40","author":[{"given":"Rajeshwar P","family":"Mookerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-33-20241201","doi-asserted-by":"crossref","first-page":"13901397","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prenisolone in acute alcoholic hepatitis.","volume":"39","author":"Naveau","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R2-33-20241201","doi-asserted-by":"crossref","first-page":"G881884","DOI":"10.1152\/ajpgi.00006.2004","article-title":"Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease.","volume":"286","author":"Rao","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R3-33-20241201","doi-asserted-by":"crossref","first-page":"507512","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis.","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"R4-33-20241201","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2004.04.028","article-title":"Soluble TNF-R1, but not TNF , predicts the 3-month mortality in patients with alcoholic hepatitis.","volume":"41","author":"Spahr","year":"2004","journal-title":"J Hepatol"},{"issue":"Suppl","key":"R5-33-20241201","first-page":"48S54S","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.","volume":"24","author":"Fujimoto","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"R6-33-20241201","doi-asserted-by":"crossref","first-page":"11821187","DOI":"10.1136\/gut.52.8.1182","article-title":"TNF is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.","volume":"52","author":"Mookerjee","year":"2003","journal-title":"Gut"},{"key":"R7-33-20241201","doi-asserted-by":"crossref","first-page":"13981405","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohns disease.","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"R8-33-20241201","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.","volume":"32","author":"Cabre","year":"2000","journal-title":"HEPATOLOGY"},{"key":"R9-33-20241201","doi-asserted-by":"crossref","first-page":"41925","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20344","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200408000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:13:42Z","timestamp":1733055222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200408000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20344","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}